NO168425C - Fremgangsmaate ved fremstilling av krystallinsk cefadroksilmonohydrat - Google Patents

Fremgangsmaate ved fremstilling av krystallinsk cefadroksilmonohydrat

Info

Publication number
NO168425C
NO168425C NO880026A NO880026A NO168425C NO 168425 C NO168425 C NO 168425C NO 880026 A NO880026 A NO 880026A NO 880026 A NO880026 A NO 880026A NO 168425 C NO168425 C NO 168425C
Authority
NO
Norway
Prior art keywords
cefadroxil
crystallinic
procedure
preparation
monohydrate
Prior art date
Application number
NO880026A
Other languages
English (en)
Norwegian (no)
Other versions
NO880026L (no
NO168425B (no
NO880026D0 (no
Inventor
Leonardo Marsili
Original Assignee
Rifar Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rifar Srl filed Critical Rifar Srl
Publication of NO880026D0 publication Critical patent/NO880026D0/no
Publication of NO880026L publication Critical patent/NO880026L/no
Publication of NO168425B publication Critical patent/NO168425B/no
Publication of NO168425C publication Critical patent/NO168425C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO880026A 1987-08-03 1988-01-05 Fremgangsmaate ved fremstilling av krystallinsk cefadroksilmonohydrat NO168425C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/080,999 US4898938A (en) 1987-08-03 1987-08-03 Method for preparing crystalline cefadroxil monohydrate

Publications (4)

Publication Number Publication Date
NO880026D0 NO880026D0 (no) 1988-01-05
NO880026L NO880026L (no) 1989-02-06
NO168425B NO168425B (no) 1991-11-11
NO168425C true NO168425C (no) 1992-02-19

Family

ID=22161022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880026A NO168425C (no) 1987-08-03 1988-01-05 Fremgangsmaate ved fremstilling av krystallinsk cefadroksilmonohydrat

Country Status (18)

Country Link
US (1) US4898938A (xx)
EP (1) EP0302145B1 (xx)
JP (1) JP2655664B2 (xx)
KR (1) KR960002910B1 (xx)
CN (1) CN1016607B (xx)
AT (1) ATE105560T1 (xx)
AU (1) AU597136B2 (xx)
CA (1) CA1285554C (xx)
DE (1) DE3789810T2 (xx)
DK (1) DK680387A (xx)
ES (1) ES2056059T3 (xx)
FI (1) FI88043C (xx)
NO (1) NO168425C (xx)
PH (1) PH23648A (xx)
PT (1) PT86526B (xx)
RU (1) RU1804461C (xx)
YU (1) YU44649B (xx)
ZA (1) ZA879701B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991000865A1 (en) * 1989-07-10 1991-01-24 Gema S.A. A novel stable form of cephradine, process for its production and intermediates used therein
US5589593A (en) * 1991-11-11 1996-12-31 Biochimica Opos Spa Crystalline form of a cephalosporin antibiotic
IT1251999B (it) * 1991-11-11 1995-05-27 Opos Biochimica Srl Forma cristallina di un antibiotico cefalosporinico
JP2005530746A (ja) * 2002-05-03 2005-10-13 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロールファーマソルブ溶媒和物
US20040077849A1 (en) * 2002-10-16 2004-04-22 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of cefadroxil
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
CN1311830C (zh) * 2004-02-27 2007-04-25 石药集团中奇制药技术（石家庄）有限公司 头孢羟氨苄口腔崩解片及其制备方法
KR101420451B1 (ko) * 2006-05-19 2014-07-16 디에스엠 시노켐 파마슈티칼스 네덜란드 비.브이. 세파드록실의 결정화 방법
CN102134250B (zh) * 2011-01-19 2013-03-13 天津大学 一种头孢羟氨苄单水合物的结晶方法及结晶
CN104447795B (zh) * 2014-11-28 2016-08-17 珠海金鸿药业股份有限公司 一种头孢羟氨苄化合物及其药物组合物
CN105534937B (zh) * 2015-12-30 2019-12-03 石药集团欧意药业有限公司 一种头孢羟氨苄片剂及其制备方法
CN106588953B (zh) * 2016-11-08 2018-11-27 山东罗欣药业集团恒欣药业有限公司 一种抗感染药物头孢羟氨苄晶型化合物及其组合物
CN106588954B (zh) * 2016-11-08 2018-11-27 山东罗欣药业集团恒欣药业有限公司 一种抗感染药物羟氨苄晶体化合物及其组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1532682A (en) * 1976-04-27 1978-11-22 Bristol Myers Co Process for the preparation of cephadroxil
US4160863A (en) * 1977-04-07 1979-07-10 Bristol-Myers Company Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid
GB8714180D0 (en) * 1987-06-17 1987-07-22 Rifar Srl Anhydrous crystalline cefadroxil
WO1988008320A1 (en) * 1987-04-24 1988-11-03 Invenmark Limited Puzzle

Also Published As

Publication number Publication date
AU597136B2 (en) 1990-05-24
PT86526A (pt) 1989-09-14
DK680387A (da) 1989-02-04
EP0302145B1 (en) 1994-05-11
DK680387D0 (da) 1987-12-22
CN1031085A (zh) 1989-02-15
PT86526B (pt) 1994-10-31
NO880026L (no) 1989-02-06
NO168425B (no) 1991-11-11
EP0302145A2 (en) 1989-02-08
JPS6442487A (en) 1989-02-14
DE3789810D1 (de) 1994-06-16
ATE105560T1 (de) 1994-05-15
CN1016607B (zh) 1992-05-13
AU8304587A (en) 1989-02-09
DE3789810T2 (de) 1994-08-18
FI88043B (fi) 1992-12-15
PH23648A (en) 1989-09-27
FI881040A (fi) 1989-02-04
NO880026D0 (no) 1988-01-05
CA1285554C (en) 1991-07-02
YU242787A (en) 1989-02-28
US4898938A (en) 1990-02-06
FI88043C (fi) 1993-03-25
ES2056059T3 (es) 1994-10-01
KR960002910B1 (ko) 1996-02-28
KR890003775A (ko) 1989-04-18
ZA879701B (en) 1988-06-23
YU44649B (en) 1990-10-31
JP2655664B2 (ja) 1997-09-24
FI881040A0 (fi) 1988-03-07
EP0302145A3 (en) 1989-08-23
RU1804461C (ru) 1993-03-23

Similar Documents

Publication Publication Date Title
NO905608L (no) Fremgangsmaate for fremstilling av a-nor-steroid-3-karboksylsyrederivater.
NO880026D0 (no) Fremgansmaate ved fremstilling av krystallinsk cefadroksilmonohydrat.
DK103982A (da) Beta-laktam-eddikesyrederivater og deres anvendelse samt fremgangsmaade til fremstilling deraf og af 1-azabicyklo(3.2.0)-hept-2-en-antibiotika
DE3852560D1 (de) Kristallines Cefadroxil und Verfahren zu dessen Herstellung.
DE3780454D1 (de) Im wesentlichen wasserfreies kristallines cefadroxil und verfahren zu dessen herstellung.
NO823930L (no) Fremgangsmaate til fremstilling av cephalosporinderivater som i 3-stilling har en tiometylgruppe med en heterocyklisk ring
YU199985A (en) Process for preparation of n-substituted derivatives of azyridine -2-carboxylic acids
NO169389C (no) Fremgangsmaate for fremstillng av kinolincarboxylsyrederivater